Throughout this medical market research, the publisher analyzed 13 endoscope companies in Canada and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the Canadian Endoscope market analysis, each of the market segments is also available as stand-alone MedCore reports.
Markets Covered
Canadian Endoscope Market Insights
One of the most recent innovations in the urological device market was the inception of the single-use flexible ureteroscope market, with the launch of Boston Scientific’s LithoVue™ in 2016. Due to the single-use nature of the device, the costly process of reprocessing and sterilization is eliminated. If single-use devices are developed for other urological endoscopes, unit sales could potentially grow exponentially.
Recently, there has been a trend in the Canada where ENT procedures are more commonly being performed in office settings. The increase in office procedures has led to an increase in the number of units sold, as physicians need to purchase the equipment required to perform the procedures. This trend towards office procedures is driving the overall ENT endoscopic device market.
Overall, the Canadian endoscope market was valued at $63.8 million in 2019. This is expected to increase over the forecast period, at a CAGR of 2.8%, to reach $77.6 million.
While this MedSuite report contains all of the Canadian Endoscope market analysis, each of the market segments is also available as stand-alone MedCore reports.
Markets Covered
- Cystoscope Market - MedCore
- Ureteroscope Market - MedCore
- Resectoscope Market - MedCore
- Nephroscope Market - MedCore
- ENT Endoscope Market - MedCore
- Laparoscope Market - MedCore
Canadian Endoscope Market Insights
One of the most recent innovations in the urological device market was the inception of the single-use flexible ureteroscope market, with the launch of Boston Scientific’s LithoVue™ in 2016. Due to the single-use nature of the device, the costly process of reprocessing and sterilization is eliminated. If single-use devices are developed for other urological endoscopes, unit sales could potentially grow exponentially.
Recently, there has been a trend in the Canada where ENT procedures are more commonly being performed in office settings. The increase in office procedures has led to an increase in the number of units sold, as physicians need to purchase the equipment required to perform the procedures. This trend towards office procedures is driving the overall ENT endoscopic device market.
Overall, the Canadian endoscope market was valued at $63.8 million in 2019. This is expected to increase over the forecast period, at a CAGR of 2.8%, to reach $77.6 million.
Table of Contents
LIST OF FIGURESLIST OF CHARTSEXECUTIVE SUMMARYCANADA ENDOSCOPE MARKET OVERVIEWCOMPETITIVE ANALYSISMARKET TRENDSMARKET DEVELOPMENTSMARKETS INCLUDEDVERSION HISTORYABBREVIATIONS
RESEARCH METHODOLOGY
CANADIAN ENDOSCOPE MARKET OVERVIEW
UROLOGICAL ENDOSCOPE MARKET
ENT ENDOSCOPE MARKET
LAPAROSCOPE MARKET
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ambu
- Boston Scientific
- CONMED
- Karl Storz
- KEIR Surgical
- Medtronic
- NeoScope
- Olympus
- Pentax
- Pusen
- Richard Wolf
- Stahl Endoscopy
- Stryker
